Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus

Pemphigus

Validation of 5-Point Investigator Global Assessments for Pemphigus The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus Wound Dressings for Pemphigus and Pemphigoid Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for Pemphigus Effect of Anti CD20 in Pemphigus Desease Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via Cylex Identification of Vulnerability Factors in the Course of Pemphigus Patients